References
Stumpf AN, Schmidt C, Hiddemann W, Gerbitz A (2009) High serum concentrations of ciclosporin related to administration of tigecycline. Eur J Clin Pharmacol 65:101–103
Crettol S, Venet JP, Fontana M, Aubert JD, Pascual M, Eap CB (2008) CYP3A7, CYP3A5, CYP3A4, and ABCB1 genetic polymorphisms, cyclosporine concentration, and dose requirement in transplant recipients. Ther Drug Monit 30:689–699
Hoffmann M, DeMaio W, Jordan RA et al (2007) Metabolism, excretion, and pharmacokinetics of [14C]tigecycline, a first-in-class glycylcycline antibiotic, after intravenous infusion to healthy male subjects. Drug Metab Dispos 9:1543–1553
Hesselink DA, van Hest RM, Mathot RA, Bonthuis F, Weimar W, de Bruin RW, van Gelder T (2005) Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2. Am J Transplant 5:987–994
Zimmerman JJ, Harper DM, Matschke K, Speth JL, Raible DG, Fruncillo RJ (2007) Absence of an interaction between tigecycline and digoxin in healthy men. Pharmacother 27:835–844
Igel S, Dreschler S, Murdter T et al (2007) Increased absorption of digoxin from the human jejunum due to inhibition of intestinal transporter-mediated efflux. Clin Pharmacokinet 46:777–785
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Srinivas, N.R. Tigecycline and cyclosporine interaction—an interesting case of biliary-excreted drug enhancing the oral bioavailability of cyclosporine. Eur J Clin Pharmacol 65, 543–544 (2009). https://doi.org/10.1007/s00228-009-0631-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-009-0631-x